文献速递妇产影像介入MR

比较不同无灌注体积比下HIFU消融与TCRM治疗1型和2型子宫肌瘤的再干预率

Comparison of Reintervention Rates for Type 1 and Type 2 Uterine Fibroids Treated With HIFU Ablation With Varying Non-Perfused Volume Ratios to That With TCRM.
PubMed 文献 · J Ultrasound Med · 2025-08-05

本回顾性研究纳入2012年1月至2019年12月接受HIFU或TCRM治疗的1型和2型子宫肌瘤患者,成功随访325例(HIFU组181例,TCRM组144例)。当NPVR≥70%时,HIFU术后长期再干预率与TCRM相当; Logistic回归显示年龄和长期症状缓解是再干预的独立影响因素,HIFU组年龄截断值为41.5岁。

要点

  • HIFU术后MRI评估NPVR≥70%时,长期再干预率与TCRM相当。
  • HIFU组年龄>41.5岁者再干预率10.1%,低于≤41.5岁者的34.7%。
  • 年龄和长期症状缓解是再干预的独立影响因素。

核心结论

  • HIFU是治疗大型1型和2型子宫肌瘤有效可靠的方法,提供可行的无创替代方案;NPVR≥70%可作为手术成功的技术标准。

研究设计与样本

  • 回顾性研究,纳入2012年1月至2019年12月接受HIFU或TCRM治疗的1型和2型子宫肌瘤患者,共445例入组,成功随访325例(HIFU组181例,TCRM组144例),随访率73%;HIFU术后通过MRI评估NPVR。

诊断标准与关键数值

  • NPVR≥70%(n=151)时HIFU长期再干预率与TCRM相当;HIFU组年龄截断值41.5岁(ROC分析),年龄>41.5岁者再干预率10.1%(n=79),≤41.5岁者34.7%(n=72)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The objective of this study is to investigate the correlation between long-term reintervention rates following high-intensity focused ultrasound (HIFU) ablation with varying non-perfused volume ratios (NPVR) and hysteroscopic transcervical resection of myoma (TCRM) for type 1 and 2 fibroids. Additionally, the study aims to define the technical success criteria in this context.

METHODS: This retrospective study included patients with type 1 and 2 fibroids who underwent treatment with HIFU or TCRM between January 2012 and December 2019. Follow-up assessments were conducted to monitor reintervention rates. NPVR, assessed via magnetic resonance imaging (MRI) post-HIFU treatment, served as a technical indicator for comparing reintervention outcomes between HIFU and TCRM. Logistic regression analysis was employed to identify factors influencing reintervention in patients.

RESULTS: A total of 445 patients were enrolled, with successful follow-up on 325 cases, including 181 cases in the HIFU group and 144 cases in the TCRM group, resulting in a follow-up rate of 73%. When NPVR was ≥70% (n = 151), the long-term reintervention rate following HIFU was comparable to that of TCRM. Binary logistic regression analysis revealed age and long-term symptom relief as independent influencing factors influencing reintervention. The cut-off value of age in patients from the HIFU group was determined as 41.5 using receiver operating characteristic curve (ROC) analysis. The reintervention rate was found to be 10.1% (n = 79) for patients aged over 41.5 years, compared to 34.7% (n = 72) for those aged below it.

CONCLUSION: HIFU emerges as an effective and reliable treatment modality for large type 1 and type 2 uterine fibroids, providing a viable non-invasive alternative for their management. NPVR ≥70% can serve as a technical criterion for successful operation.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Tan T, Li S, Yang Z, et al. Comparison of Reintervention Rates for Type 1 and Type 2 Uterine Fibroids Treated With HIFU Ablation With Varying Non-Perfused Volume Ratios to That With TCRM. J Ultrasound Med. 2025. PMID: 40762411. doi:10.1002/jum.70011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。